Clinical Pathology

OptraSCAN has given tissuepathology.com a rare insight into their advisory board discussions as to what their thought leaders think is important in the digital pathology space for the market. OptraSCAN is of course the first On-Demand...

In April I wrote a post entitled A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1. This was followed by a guest post by David West, CEO, Proscia, entitled AI vs MD – What it Means for Pathology in May where...

Congratulations to Dr. Rohit Bhargava. Dr. Bhargava is a professor in the UIUC Department of Bioengineering and a full-time faculty member in the Beckman Institute Bioimaging Science and Technology group.  Instruments developed in his...

Promega Corporation intends to seek FDA approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. The current Promega...

Berci Mesko, MD, PhD, The Medical Futurist, a self-proclaimed "geek physician with a PhD in genomics and Amazon Top 100 author" who envisions "the impact of digital health technologies on the future of healthcare, and helps patients, doctors,...

SAVE THE DATE! DIGITAL PATHOLOGY ASSOCIATION SESSION To take place at the 29th European Congress of Pathology Sunday, September 3, 2017 | 2:45-5:15 PM Amsterdam, The Netherlands Presentations Include: Computational Pathology and...